Highly efficient intranasal H5N1 vaccine based on a safe vesicular stomatitis virus (VSV) vector
This study constructed a high-expression 6-9G recombinant replication-competent VSV vector.
‘Healthy ageing’ messaging in vaccine promotion among older adults: evaluation of vaccine intention in a survey using a social marketing methodology
This study aimed to identify key elements of the social marketing 5P framework that may improve vaccination intention and ultimately vaccination uptake.
State-of-the-art of the high dose influenza vaccine in Spain
Review article - To describe the introduction, uptake, and current use of HD influenza vaccines in Spain and to summarize the evidence supporting their broader adoption in adults ≥60 years of age.
Vaccination policies for healthcare personnel in Europe, 2026
European countries have more comprehensive vaccination policies for HCP compared with 2018, however there are still significant differences between countries.
Do vaccinated cases transmit measles? A systematic review and meta-analysis
Conclusion: Measles transmissions from vaccinated cases, although relatively uncommon, must be considered in public health investigations, as such transmissions can contribute to outbreaks.
Vaccine Effectiveness and Safety for the 2026-2027 Respiratory Season - COVID-19, RSV, Influenza
JAMA Special Communications - Three systematic reviews identify & summarise recent reporting on the effectiveness and safety of vaccines and influenza/RSV/Covid-19 epidemiology in the US.
Trends in childhood vaccination coverage in the European Union, 1980–2024: an ecological time-series study
Despite long-term gains, recent EU-wide coverage declines signal increasing risks to herd and individual immunity.
WHO prequalifies multi-dose RSV vaccine vial, paving the way to protecting more infants globally
The WHO has prequalified the multi-dose vial presentation of the maternal respiratory syncytial virus (RSV) vaccine, RSVpreF (ABRYSVO®).
